Cytotoxic chemotherapy, radiotherapy and drug resistance I Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What are the current cancer treatments?

A
  • surgery - highly successful for localised primary disease
  • radiotherapy - external beam, intracavity, radioimmunotherapy (zevalin)
  • chemotherapy - applicable to systemic metastasised disease
  • immunotherapy (inc. vaccines, eg. cervarix)
  • gene therapy (eg. GDEPT)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List some stats on 5 yr survival of non small cell lung cancer (NSCLC) by stage

A
  • stage I/II localised disease - surgery 45-70%
  • stage III localised advanced - XRT/chemo= 10-25%
  • stage IV metastatic - chemo <5%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is adjuvant therapy?

A
  • chemotherapy following primary surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is neoadjuvant therapy?

A
  • chemotherapy to reduce the bulk of primary tumours prior to surgery or radiotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the fractional cell kill hypothesis for chemotherapy?

A
  • a given drug concentration applied for a defined time period will kill a constant fraction of the cell population, independent of the absolute number of cells
  • survival is inversely related to tumour burden: a single leukaemic cell is capable of multiplying to kill the host
  • implications : tumour best treated whet they are small and treatment should continue until last cell is dead
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the classes of anticancer drugs?

A
  • DNA interactive (alkylating mustards, cyclophosphamide, chlorambucil, cisplatin)
  • block DNA synthesis (antimetabolites, 5FU, methotrexate)
  • affect DNA processing (doxorubicin, etoposide)
  • block mitosis (tubulin, vinca alkaloids)
  • hormone based (anti-oestrogen)
  • molecularly targeted therapy - monoclonal antibodies (rituximab, trastuzumab)
  • signal transduction inhibitors (RTKIs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What phase-dependent drugs affect the S-phase?

A
  • ara C
  • hydroxyurea
  • methotrexate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What drugs are phase dependent that affect G2/mitosis?

A
  • etoposide
  • vincas
  • taxanes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some phase-independent drugs?

A
  • alkylating agents
  • nitrosoureas
  • mitomycin C
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What drugs cause haematological toxicity?

A
  • myelosuppresion - risk of infection

- thrombocytopenia - risk of haemorrhage - may be delayed with some drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What drugs cause gastrointestinal toxicitiy?

A
  • cisplatin - nausea and vomiting

- irinotecan - diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What other toxicities are caused by drugs?

A
  • alopecia - cyclophosphamide
  • pulmonary - bleomycin
  • cardiac toxicity - doxorubicin
  • renal - cisplatin
  • bladder toxicity - ifosfamide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the tumour response to drugs?

A
  • CR - complete response = complete resolution of all measurable disease for at least one month
  • PR - partial response = 50% reduction in the product of two perpendicular diameters for one month or more
  • SD - stable disease = ‘o change in size of measurable tumour over a period of one month or more’
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the steps involved in finding new cancer drugs?

A
  • target identification (cell growth and molecular biology)
  • hit identification (screening design)
  • lead optimisation (chemistry, pharmacology)
  • preclinical development (manufacture, formulation
  • clinical trials (regulatory approval)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe phase I of clinical trials for anticancer drugs

A
  • regulatory filling, IND
  • generally performed in cancer patients rather than healthy volunteers - bc low TI
  • 20-30 patients
  • what is maximum dose tolerated in patients?
  • what is the dose limiting toxicity?
  • anti-tumour activity NOT primary aim
  • increasing emphasis on pharmacodynamics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is dose escalation in phase I trials?

A
  • fundamental conflict
  • too fast = may get sudden jump from no toxicity to life-threatening
  • too slow - large numbers of patients treated at ineffective doses, slower entry into phase II
  • modified fibonacci scheme used
17
Q

Describe phase II of clinical trials for anticancer drugs

A

‘learning’

  • goal to assess probability of positive risk to benefit ratio in phase III
  • generally single agent, single tumour type
  • single arm vs historical control
  • randomised control trial (RCT)
18
Q

Describe phase II of clinical trials for anticancer drugs

A

‘learning’

  • goal to assess probability of positive risk to benefit ratio in phase III
  • generally single agent, single tumour type
  • single arm vs historical control
  • randomised control trial (RCT)
19
Q

Describe phase II of clinical trials for anticancer drugs

A

‘confirming’

  • is the drug more effective than established therapy
  • randomised clinical trials
20
Q

What are the future directions?

A
  • individualisation of chemotherapy - based on tumour genotype or microarrays
  • better detection (imaging, blood markers, susceptibility genes BRCA1/2)
  • better prevention - diet
21
Q

What drugs are used in metastatic colorectal cancer?

A
  • 5FU
  • irinotecan, oxaliplatin
  • capecitabine (oral 5FU + DPD inhibitor)